Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "PEComa - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Perivascular epithelioid cell neoplasms (PEComas) are ...
A 42-year-old male was admitted to our observation with dyspnea, temperature, abdominal discomfort and weight loss. He had previously experienced tuberculosis infection, and his past surgical history ...
As a passionate dancer, Cristina enjoyed an active life of dancing jazz, musical theater, Latin and belly dancing for many years. However, after a routine visit to her doctor in 2013, Cristina’s world ...
Announcing a new article publication for BIO Integration journal. Hepatic perivascular epithelioid cell tumor (PEComa) is a rare tumor with malignant potential that is frequently misdiagnosed as ...
After 3 years of follow-up in AMPECT trial, confirmed clinically meaningful overall response rate, including multiple patients with complete responses "The data published in JCO highlight the ...
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "PEComa - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides ...
(RTTNews) - Aadi Bioscience, Inc. (AADI), a company focused on precision therapies, said on Tuesday that the U.S. Food and Drug Administration or FDA has approved FYARRO, sirolimus protein-bound ...
Perivascular epithelioid cell neoplasms (PEComas) are rare soft tissue tumors that primarily form around small blood vessels in various body parts, such as the lungs, GI tract, kidneys, liver, and ...
Background: Malignant perivascular epitheliod cell tumor (PEComa) is a very rare entity composed of distinctive perivascular epitheliod cells with variable immunoreactivity for melanocytic and muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results